Zyvox Not Major Treatment Expense, CMS Says; Add-On Payments Denied
Executive Summary
Pharmacia's Zyvox is not a significant factor in the total cost of treating patients receiving the product, the Centers for Medicare & Medicaid Services determined in denying add-on payments for the antibiotic